IGF1 and cancer: In contrast, pathways that have been proposed to explain T2DM‐cancer associations (hyperinsulinemia, hyperglycemia, IGF signaling, and inflammation) have also been proposed as possible mediators for the BMI‐cancer relationship.7, 35, 36, 37, 38, 39